Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity.

1F , G , H and I and Table 3 ). Effects on organ weights The DIO + O-1602-treated group had reduced epididymal fat depots when compared with the DIO control group, there was also a nonsignificant trend ( P = 0.077, total mass and P = 0.074, percentage of body weight) for peri-renal fat pad depots to be reduced ( Table 4 ).

also in 5,406 other papers